AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AEVIS VICTORIA SA

Investor Presentation Apr 29, 2011

808_ip_2011-04-29_5ce6a576-e823-4c3f-8810-cfcea623d167.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

GENOLIER SWISS MEDICAL NETWORK ANNUAL RESULTS 2010

RAYMOND LORETAN

PRESIDENT OF THE BOARD OF DIRECTORS

MESSAGE TO THE SHAREHOLDER

  • 2010 ended on a subdued note following the events of the summer
  • oBoard of Directors of GSMN is working to correct the negative effects
  • Focus on the future with a confirmed growth and development strategy
  • Stable shareholder base who identifies with the Group's vision
  • Our vision remains creation of a major healthcare player in Switzerland with a presence in the majority of the cantons
  • oAcquisition of a minority stake in Klinik Lindberg

CORPORATE GOVERNANCE -BOARD OF DIRECTORS

  • Raymond Loretan– Executive Dr Philippe Glasson – Vice ChairmanVice-chairman
  • Antoine Hubert – Managing Director
  • Me Antoine Kohler
  • Johannes Boot
  • Dr Christian Le Dorze
  • Dr Cédric A. George

MAJOR SHAREHOLDERS

ANTOINE HUBERT

MANAGINGDIRECTOR

ANNUAL RESULTS 2010

  • Strong pdue to acquisitionsng progress of revenue and EBITDA
  • Sales were 38% higher at CHF 192.3 million (CHF 139.3 m)
  • EBITDA CHF 15.2 millionDA (Swiss GAAP) gained 45.6% at
  • o Reflecting the improvement of operating profitability and lower ordinary expenditures
  • Net results for 2010 adversely affected
  • o Extraordinary costs linked to last summer's events
  • o Exceptional tax charge resulting from the forecast reduction

CLINIQUE DE GENOLIER HIGHLIGHTS

  • Flagship of the Group with CHF 72.7 million, i.e. 37.8% of the Groups' turnover
  • Genolier has clearly failed to reach its objectives in 2010
  • The business in the first months of 2011 show that growth has returnedthe Group 72.7 i.e. 37.8% turnover in that compaired
  • EBITDA has improved slightly with 2009
  • Focus on the recruitment of new doctors to support growthFocus on recruitment new doctors growth
  • New operating theatre to be inaugurated in June 2011, offering 25% more capacityinaugurated in

PRIVATKLINIK BETHANIENHIGHLIGHTS

  • Turnover of CHF 52 million and EBITDA of CHF 6 millionof CHF to
  • Important work has been carried out to improve the clinic's medical offering and hotel services
  • o New maternity, new VIP rooms VIP
  • An underground carunder constructionAn car-park is currently
  • Bethanienreputation for many years and has enormous potential for development has enjoyed a solid medical and
  • Bethanienplatform in German will serve as the development German-speaking Switzerland

CLINIQUE DE MONTCHOISIHIGHLIGHTS

  • Montchoisi almost CHF 19 million (+12%) realised a turnover of
  • EBITDA in 2010 rose 14% to CHF 3 million
  • Best productivity per bed and m2
  • A cutting edge radiology centre, a car park with 45 parking spaces and a restaurant have been created
  • Ophthalmology remains the clinic's beacon discipline

OTHER ENTITIES' HIGHLIGHTS

Clinique Générale

  • o Price pressure has slightly eroded the turnover andEBITDA has eroded rooms completed
  • oNew private rooms completed the existing offering
  • Clinique ValmontValmont
  • o Focus on neurological and orthopaedic rehabilitation
  • o Turnover down by more than 22% (CHF 10.5 million) but improved EBITDATurnover more 22%
  • Centre médicomédico-chirurgical des Eaux-Vives
  • oStrengthening of its medical team
  • oExceptional technical facilities
  • o CMEV is offering radiotherapy and multidisciplinary oncology treatments.its medical team technical CMEV radiotherapy and

Les Hautsde Genolier

  • o The secure and Genolier" is meeting with growing successtreatments.The secure and medicalized residence "Les Hauts de
  • o Expenses related to its opening had a negative impact on GSMN's results in 2010Genolier" Expenses its had 2010

BEAT ROTHLISBERGER

CEO

BALANCE SHEET

(
'0
)
0
0
C
1
H
F
x
2
0
0
1
2
0
0
9
l
h
l
B
t
t
t
a
a
n
c
e
s
e
e
o
a
'
1
4
5
1
2
5
'
9
5
3
6
1
(
'0
0
0
C
)
1
H
F
x
2
0
0
1
2
0
0
9

INCOMESTATEMENT

(
'0
0
0
)
1
C
H
F
x
2
0
0
1
2
0
0
9
R
e
e
n
e
s
v
u
'
9
2
3
1
7
7
'
3
9
3
3
2
1
O
i
t
t
p
e
a
n
g
c
o
s
s
r
(
'
3
3
)
1
6
6
6
(
8
'4
2
9
)
1
1
E
B
I
T
D
A
'
9
1
5
1
4
'
0
0
1
4
5
f
f
P
i
i
i
i
i
t
t
t
t
o
o
m
o
p
e
a
n
g
a
c
e
s
r
r
r
v
'
1
3
7
8
'
1
3
8
6
l
l
i
i
F
t
n
a
n
c
a
e
s
r
u
(
'1
)
2
2
9
(
'4
)
1
1
3
(
/
)
I
I
I
t
n
c
o
m
e
a
e
e
p
e
n
s
e
n
n
c
c
o
o
m
m
e
e
x
x
(
'5
)
2
1
4
7
4
7
d
l
E
i
t
t
o
n
e
x
r
a
r
a
r
y
r
s
u
(
'
)
8
8
4
4
'
3
0
0
7
(
)
/
f
f
h
d
L
i
i
t
t
o
p
o
o
e
p
e
o
s
s
r
r
r
(
'
)
2
3
7
1
'
3
2
6
7

OPERATIONALCASH FLOW

Operational cash flow was 38.8% higher at CHF 13.6 million

2010 REVENUE BREAKDOWN

Turnover increased by 38% to CHF (vs. CHF 139.3m)192.1 million

ANTOINE HUBERT

MANAGINGDIRECTOR

2011 REALISATION -PARTNERSHIP WITH KLINIK LINDBERG

  • From July 2011, 49% participating interest in Lindberg
  • Possibility for GSMN to acquire the reminaining 51%
  • Management contract withGSMN from May 2011
  • Strategic partnerschift positioningstrong entity in the GSMN Klinik Lindberg as a network
  • New Board of Director with as of July 20112 respresentatives of GSMN

WHY KLINIKLINDBERG?

  • Klinik Lindberg is a well-known clinic in Winterthur – the only private one
  • Strong brand
  • Quality Medical care and hotel services
  • Complementary medical specialties with GSMN
  • Strong link with Bethanien in Zurich region

Q1 2011 RESULTS

C
Q
G
O
L
I
N
I
U
E
D
E
E
N
L
I
E
R
2
0
0
1
2
0
1
1
%
T
n
o
e
u
r
v
r
'2
1
7
9
6
'5
1
8
8
4
7
4
*
E
B
I
T
D
A
2
'1
8
4
3
'1
8
7
9
4
5
C
L
I
N
I
Q
U
E
D
E
M
O
N
T
C
H
O
I
S
I
2
0
1
0
2
0
1
1
T
u
r
n
o
v
e
r
'8
9
4
7
'6
5
1
4
1
5
1
*
E
B
I
T
D
A
8
5
4
9
7
4
1
4
1
C
L
I
N
I
Q
U
E
G
E
N
E
R
A
L
E
2
0
1
0
2
0
1
1
%
T
u
r
n
o
v
e
r
'7
9
2
7
'5
0
7
1
3
7
-
*
E
B
I
T
D
A
'2
1
4
9
7
5
9
3
9
2
-
P
R
I
V
A
T
K
L
I
N
I
K
B
E
T
H
A
N
I
E
N
2
0
1
0
2
0
1
1
T
n
o
e
u
r
v
r
'2
1
3
1
2
'8
1
2
0
7
3
1
-
*
E
B
I
T
D
A
'6
1
1
0
'3
2
7
0
4
7
2
C
L
I
N
I
Q
U
E
V
A
L
M
O
N
T
2
0
1
0
2
0
1
1
%
T
n
o
e
u
r
v
r
'6
2
4
2
'9
2
9
9
1
3
5
*
E
B
I
T
D
A
2
1
-
3
6
8
'8
2
1
5
C
M
E
V
2
0
1
0
2
0
1
1
%
T
u
r
n
o
v
e
r
'0
2
9
0
'3
8
2
4
1
2
4
*
E
B
I
T
D
A
2
7
5
2
4
8
-
1
9
0
0
-
S
G
O
H
A
U
T
D
E
E
N
L
I
E
R
2
0
0
1
2
0
1
1
%
T
n
o
e
u
r
v
r
6
0
2
'0
1
8
7
8
0
6
*
E
B
I
T
D
A
2
6
4
1
5
1
-
6
3
1
1
-
O
G
O
T
T
A
L
R
U
P
E
2
0
0
1
2
0
1
1
%
T
n
o
e
u
r
v
r
'5
4
8
1
2
'9
5
0
4
1
5
0
*
E
B
I
T
D
A
'3
6
9
7
'2
7
5
8
1
3
5
h
d
G
o
p
o
e
e
a
s
r
u
v
r
'3
2
0
3
-
'8
1
3
5
-
2
0
4
-
G
R
O
U
P
E
B
I
T
D
A
'0
4
9
4
'4
5
2
3
3
2
4

2011 OBJECTIVES

GSMN expects to realise a turnover of CHF 200 million (based on an unchanged portfolio)

RAYMOND LORETAN

PRESIDENT OF THE BOARD OF DIRECTORS

LAMAL KVG REVISION 2012

GSMN favors a healthy competitionpublic clinics between private an

oQuality and cost control

  • Clinique de Genolier, Clinique de Montchoisi, Clinique Valmont and Bethanien will not go on the Hospital lists
  • oConclusion of service contracts
  • o Remain partners for cantonal health coverage
  • Clinique Générale in Fribourg figures on the listsHospital

2011 OBJECTIVES

  • Other acquisitions are currently being explored andnegotiated and should soon allow GSMN to exceed theCHF 300 million turnover mark.
  • GSMN's clinics have important organic growth capacity
  • oRecruitment of new doctors
  • oIntensive development of the agent network
  • oStrong accent will be placed on preventive medicine
  • Continue to work on productivity and cost control
  • Development of "NescensNescens" and preventive medicine
  • o Cosmeceutical line designed to prevent aging created by Genolier Laboratoires

QUESTIONS AND ANSWERS

Talk to a Data Expert

Have a question? We'll get back to you promptly.